Bortezomib in Intrahepatic Cholangiocellular Carcinoma

Condition:   Intrahepatic Cholangiocarcinoma Intervention:   Drug: Bortezomib Sponsor:   Zhengang Yuan Recruiting

Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials